November 22, 2024
Science

Promising malaria vaccine candidate proves its worth in a Phase II trial with over 80% efficacy

<

You might also like

Gene Expression Shifts as Shrews Shrink and Regrow Their Brains

18 Times More Power: MIT Researchers Have Developed Ultrathin Lightweight Solar Cells

Some Star Systems Create a Planet Sandwich

Scientists Warn: Rate of Human-Caused Global Warming at All-Time High